A 0 1 0 1 O
history 2 9 2 9 O
of 10 12 10 12 O
amblyopia 13 22 13 22 B-chronic_disease
in 23 25 23 25 O
the 26 29 26 29 O
study 30 35 30 35 O
eye 36 39 36 39 O

Active 0 6 40 46 B-chronic_disease
ocular 7 13 47 53 I-chronic_disease
infection 14 23 54 63 I-chronic_disease
or 24 26 64 66 O
inflammation 27 39 67 79 B-chronic_disease
, 39 40 79 80 O
or 41 43 81 83 O
any 44 47 84 87 O
history 48 55 88 95 O
of 56 58 96 98 O
intraocular 59 70 99 110 B-chronic_disease
inflammation 71 83 111 123 I-chronic_disease
, 83 84 123 124 O
that 85 89 125 129 O
would 90 95 130 135 O
expose 96 102 136 142 O
subject 103 110 143 150 O
to 111 113 151 153 O
risk 114 118 154 158 O
during 119 125 159 165 O
or 126 128 166 168 O
following 129 138 169 178 O
surgery 139 146 179 186 B-treatment

Be 0 2 187 189 O
adult 3 8 190 195 O
male 9 13 196 200 B-gender
or 14 16 201 203 I-gender
female 17 23 204 210 I-gender

Cataract 0 8 211 219 B-treatment
surgery 9 16 220 227 I-treatment
in 17 19 228 230 O
the 20 23 231 234 O
study 24 29 235 240 O
eye 30 33 241 244 O
or 34 36 245 247 O
ocular 37 43 248 254 B-treatment
surgery 44 51 255 262 I-treatment
in 52 54 263 265 O
either 55 61 266 272 O
eye 62 65 273 276 O
( 66 67 277 278 O
which 67 72 278 283 O
in 73 75 284 286 O
the 76 79 287 290 O
opinion 80 87 291 298 O
of 88 90 299 301 O
the 91 94 302 305 O
investigator 95 107 306 318 O
may 108 111 319 322 O
have 112 116 323 327 O
an 117 119 328 330 O
impact 120 126 331 337 O
on 127 129 338 340 O
patient 130 137 341 348 O
safety 138 144 349 355 O
or 145 147 356 358 O
the 148 151 359 362 O
integrity 152 161 363 372 O
of 162 164 373 375 O
data 165 169 376 380 O
from 170 174 381 385 O
the 175 178 386 389 O
study 179 184 390 395 O
eye 185 188 396 399 O
) 188 189 399 400 O
during 190 196 401 407 O
the 197 200 408 411 O
study 201 206 412 417 O
or 207 209 418 420 O
within 210 216 421 427 O
3 217 218 428 429 B-upper_bound
months 219 225 430 436 I-upper_bound
prior 226 231 437 442 I-upper_bound
to 232 234 443 445 O
treatment 235 244 446 455 B-treatment

Females 0 7 456 463 B-gender
of 8 10 464 466 O
childbearing 11 23 467 479 O
potential 24 33 480 489 O
must 34 38 490 494 O
have 39 43 495 499 O
a 44 45 500 501 O
confirmed 46 55 502 511 O
negative 56 64 512 520 B-pregnancy
pregnancy 65 74 521 530 I-pregnancy
test 75 79 531 535 O
at 80 82 536 538 O
Visits 83 89 539 545 O
1 90 91 546 547 O
and 92 95 548 551 O
2 96 97 552 553 O

Free 0 4 554 558 O
of 5 7 559 561 O
any 8 11 562 565 O
other 12 17 566 571 O
systemic 18 26 572 580 O
condition 27 36 581 590 O
that 37 41 591 595 O
in 42 44 596 598 O
the 45 48 599 602 O
opinion 49 56 603 610 O
of 57 59 611 613 O
the 60 63 614 617 O
Investigator 64 76 618 630 O
may 77 80 631 634 O
have 81 85 635 639 O
an 86 88 640 642 O
impact 89 95 643 649 O
on 96 98 650 652 O
the 99 102 653 656 O
safety 103 109 657 663 O
of 110 112 664 666 O
the 113 116 667 670 O
subject 117 124 671 678 O
, 124 125 678 679 O
conduct 126 133 680 687 O
of 134 136 688 690 O
study 137 142 691 696 O
procedures 143 153 697 707 O
, 153 154 707 708 O
or 155 157 709 711 O
integrity 158 167 712 721 O
of 168 170 722 724 O
study 171 176 725 730 O
data 177 181 731 735 O
( 182 183 736 737 O
e.g. 183 187 737 741 O
severe 188 194 742 748 O
cardiovascular 195 209 749 763 B-chronic_disease
or 210 212 764 766 O
respiratory 213 224 767 778 B-chronic_disease
disease 225 232 779 786 I-chronic_disease
; 232 233 786 787 O
poorly 234 240 788 794 O
controlled 241 251 795 805 O
diabetes 252 260 806 814 B-chronic_disease
; 260 261 814 815 O
significant 262 273 816 827 O
psychiatric 274 285 828 839 B-chronic_disease
impairment 286 296 840 850 I-chronic_disease
) 296 297 850 851 O

Have 0 4 852 856 O
Best 5 9 857 861 B-clinical_variable
Corrected 10 19 862 871 I-clinical_variable
ETDRS 20 25 872 877 I-clinical_variable
visual 26 32 878 884 I-clinical_variable
acuity 33 39 885 891 I-clinical_variable
of 40 42 892 894 O
35 43 45 895 897 B-upper_bound
letters 46 53 898 905 I-upper_bound
or 54 56 906 908 O
less 57 61 909 913 O
( 62 63 914 915 O
approximately 63 76 915 928 O
20/200 77 83 929 935 B-lower_bound
or 84 86 936 938 O
worse 87 92 939 944 O
) 92 93 944 945 O
in 94 96 946 948 O
the 97 100 949 952 O
study 101 106 953 958 O
eye 107 110 959 962 O
for 111 114 963 966 O
cohorts 115 122 967 974 O
1 123 124 975 976 O
- 124 125 976 977 O
5 125 126 977 978 O

Have 0 4 979 983 O
clinical 5 13 984 992 O
diagnosis 14 23 993 1002 O
of 24 26 1003 1005 O
RP 27 29 1006 1008 B-chronic_disease

High 0 4 1009 1013 B-chronic_disease
myopia 5 11 1014 1020 I-chronic_disease
( 12 13 1021 1022 O
> 13 14 1022 1023 O
6 14 15 1023 1024 B-lower_bound
diopters 16 24 1025 1033 B-clinical_variable
) 24 25 1033 1034 O
in 26 28 1035 1037 O
the 29 32 1038 1041 O
study 33 38 1042 1047 O
eye 39 42 1048 1051 O

History 0 7 1052 1059 O
of 8 10 1060 1062 O
any 11 14 1063 1066 O
retinal 15 22 1067 1074 B-chronic_disease
and/or 23 29 1075 1081 O
macular 30 37 1082 1089 B-chronic_disease
disease 38 45 1090 1097 I-chronic_disease
other 46 51 1098 1103 O
than 52 56 1104 1108 O
RP 57 59 1109 1111 B-chronic_disease
( 60 61 1112 1113 O
e.g. 61 65 1113 1117 O
retinal 66 73 1118 1125 O
detachment 74 84 1126 1136 O
) 84 85 1136 1137 O
that 86 90 1138 1142 O
in 91 93 1143 1145 O
the 94 97 1146 1149 O
opinion 98 105 1150 1157 O
of 106 108 1158 1160 O
the 109 112 1161 1164 O
Investigator 113 125 1165 1177 O
may 126 129 1178 1181 O
have 130 134 1182 1186 O
an 135 137 1187 1189 O
impact 138 144 1190 1196 O
on 145 147 1197 1199 O
the 148 151 1200 1203 O
safety 152 158 1204 1210 O
of 159 161 1211 1213 O
the 162 165 1214 1217 O
subject 166 173 1218 1225 O
, 173 174 1225 1226 O
conduct 175 182 1227 1234 O
of 183 185 1235 1237 O
study 186 191 1238 1243 O
procedures 192 202 1244 1254 O
, 202 203 1254 1255 O
or 204 206 1256 1258 O
integrity 207 216 1259 1268 O
of 217 219 1269 1271 O
study 220 225 1272 1277 O
data 226 230 1278 1282 O

Medically 0 9 1283 1292 O
fit 10 13 1293 1296 O
enough 14 20 1297 1303 O
to 21 23 1304 1306 O
undertake 24 33 1307 1316 O
surgery 34 41 1317 1324 B-treatment
which 42 47 1325 1330 O
may 48 51 1331 1334 O
require 52 59 1335 1342 O
general 60 67 1343 1350 B-treatment
anesthesia 68 78 1351 1361 I-treatment

Negative 0 8 1362 1370 O
serology 9 17 1371 1379 O
for 18 21 1380 1383 O
human 22 27 1384 1389 B-chronic_disease
immunodeficiency 28 44 1390 1406 I-chronic_disease
virus 45 50 1407 1412 I-chronic_disease
( 51 52 1413 1414 I-chronic_disease
HIV 52 55 1414 1417 I-chronic_disease
) 55 56 1417 1418 I-chronic_disease
, 56 57 1418 1419 O
hepatitis 58 67 1420 1429 B-chronic_disease
B 68 69 1430 1431 I-chronic_disease
( 70 71 1432 1433 I-chronic_disease
HBV 71 74 1433 1436 I-chronic_disease
) 74 75 1436 1437 I-chronic_disease
, 75 76 1437 1438 O
hepatitis 77 86 1439 1448 B-chronic_disease
C 87 88 1449 1450 I-chronic_disease
( 89 90 1451 1452 I-chronic_disease
HCV 90 93 1452 1455 I-chronic_disease
) 93 94 1455 1456 I-chronic_disease

No 0 2 1457 1459 O
history 3 10 1460 1467 O
of 11 13 1468 1470 O
malignancy 14 24 1471 1481 B-cancer
, 24 25 1481 1482 O
except 26 32 1483 1489 O
non 33 36 1490 1493 B-cancer
- 36 37 1493 1494 I-cancer
melanoma 37 45 1494 1502 I-cancer
skin 46 50 1503 1507 I-cancer
cancer 51 57 1508 1514 I-cancer
; 57 58 1514 1515 O
pre 59 62 1516 1519 B-cancer
- 62 63 1519 1520 I-cancer
malignant 63 72 1520 1529 I-cancer
conditions 73 83 1530 1540 I-cancer
and 84 87 1541 1544 O
cancer 88 94 1545 1551 B-cancer
in 95 97 1552 1554 I-cancer
situ 98 102 1555 1559 I-cancer

Participation 0 13 1560 1573 O
in 14 16 1574 1576 O
any 17 20 1577 1580 B-treatment
clinical 21 29 1581 1589 I-treatment
study 30 35 1590 1595 I-treatment
involving 36 45 1596 1605 I-treatment
an 46 48 1606 1608 I-treatment
investigational 49 64 1609 1624 I-treatment
drug 65 69 1625 1629 I-treatment
or 70 72 1630 1632 I-treatment
device 73 79 1633 1639 I-treatment
within 80 86 1640 1646 O
6 87 88 1647 1648 B-upper_bound
months 89 95 1649 1655 I-upper_bound
prior 96 101 1656 1661 I-upper_bound
to 102 104 1662 1664 O
treatment 105 114 1665 1674 B-treatment

Presence 0 8 1675 1683 O
of 9 11 1684 1686 O
ocular 12 18 1687 1693 B-chronic_disease
disease 19 26 1694 1701 I-chronic_disease
or 27 29 1702 1704 O
ocular 30 36 1705 1711 B-chronic_disease
media 37 42 1712 1717 I-chronic_disease
opacity 43 50 1718 1725 I-chronic_disease
in 51 53 1726 1728 O
the 54 57 1729 1732 O
study 58 63 1733 1738 O
eye 64 67 1739 1742 O
, 67 68 1742 1743 O
which 69 74 1744 1749 O
in 75 77 1750 1752 O
the 78 81 1753 1756 O
opinion 82 89 1757 1764 O
of 90 92 1765 1767 O
the 93 96 1768 1771 O
Investigator 97 109 1772 1784 O
, 109 110 1784 1785 O
will 111 115 1786 1790 O
preclude 116 124 1791 1799 O
an 125 127 1800 1802 O
accurate 128 136 1803 1811 O
evaluation 137 147 1812 1822 O
at 148 150 1823 1825 O
any 151 154 1826 1829 O
time 155 159 1830 1834 O
during 160 166 1835 1841 O
the 167 170 1842 1845 O
study 171 176 1846 1851 O

Prior 0 5 1852 1857 B-treatment
vitrectomy 6 16 1858 1868 I-treatment
in 17 19 1869 1871 I-treatment
the 20 23 1872 1875 I-treatment
study 24 29 1876 1881 I-treatment
eye 30 33 1882 1885 I-treatment

Use 0 3 1886 1889 O
of 4 6 1890 1892 O
systemic 7 15 1893 1901 B-treatment
immunosuppressive 16 33 1902 1919 I-treatment
agents 34 40 1920 1926 I-treatment
( 41 42 1927 1928 O
e.g. 42 46 1928 1932 O
corticosteroid 47 61 1933 1947 B-treatment
) 61 62 1947 1948 O
in 63 65 1949 1951 O
the 66 69 1952 1955 O
6 70 71 1956 1957 B-upper_bound
months 72 78 1958 1964 I-upper_bound
prior 79 84 1965 1970 I-upper_bound
to 85 87 1971 1973 O
treatment 88 97 1974 1983 B-treatment

breastfeeding 0 13 1984 1997 O
or 14 16 1998 2000 O
planning 17 25 2001 2009 B-pregnancy
a 26 27 2010 2011 I-pregnancy
pregnancy 28 37 2012 2021 I-pregnancy

inhaled 0 7 2022 2029 B-treatment
, 7 8 2029 2030 O
intranasal 9 19 2031 2041 B-treatment
, 19 20 2041 2042 O
and/or 21 27 2043 2049 O
topical 28 35 2050 2057 B-treatment
dermatologic 36 48 2058 2070 I-treatment
steroids 49 57 2071 2079 I-treatment

over 0 4 2080 2084 O
18 5 7 2085 2087 B-lower_bound
years 8 13 2088 2093 I-lower_bound
of 14 16 2094 2096 O
age 17 20 2097 2100 B-age

subjects 0 8 2101 2109 O
who 9 12 2110 2113 O
have 13 17 2114 2118 O
received 18 26 2119 2127 O
autologous 27 37 2128 2138 B-treatment
bone 38 42 2139 2143 I-treatment
marrow 43 49 2144 2150 I-treatment
stem 50 54 2151 2155 I-treatment
cell 55 59 2156 2160 I-treatment
transplant 60 70 2161 2171 I-treatment
will 71 75 2172 2176 O
be 76 78 2177 2179 O
eligible 79 87 2180 2188 O

willing 0 7 2189 2196 B-contraception_consent
to 8 10 2197 2199 I-contraception_consent
use 11 14 2200 2203 I-contraception_consent
reliable 15 23 2204 2212 I-contraception_consent
method 24 30 2213 2219 I-contraception_consent
of 31 33 2220 2222 I-contraception_consent
contraception 34 47 2223 2236 I-contraception_consent
( 48 49 2237 2238 O
e.g. 49 53 2238 2242 O
oral 54 58 2243 2247 B-contraception_consent
contraceptive 59 72 2248 2261 I-contraception_consent
and 73 76 2262 2265 I-contraception_consent
condom 77 83 2266 2272 I-contraception_consent
, 83 84 2272 2273 O
intra 85 90 2274 2279 B-contraception_consent
- 90 91 2279 2280 I-contraception_consent
uterine 91 98 2280 2287 I-contraception_consent
device 99 105 2288 2294 I-contraception_consent
( 106 107 2295 2296 I-contraception_consent
IUD 107 110 2296 2299 I-contraception_consent
) 110 111 2299 2300 I-contraception_consent
and 112 115 2301 2304 I-contraception_consent
condom 116 122 2305 2311 I-contraception_consent
, 122 123 2311 2312 O
diaphragm 124 133 2313 2322 B-contraception_consent
with 134 138 2323 2327 I-contraception_consent
spermicide 139 149 2328 2338 I-contraception_consent
and 150 153 2339 2342 I-contraception_consent
condom 154 160 2343 2349 I-contraception_consent
) 160 161 2349 2350 O
for 162 165 2351 2354 O
the 166 169 2355 2358 O
duration 170 178 2359 2367 O
of 179 181 2368 2370 O
this 182 186 2371 2375 O
study 187 192 2376 2381 O

